AIDS

1. WONG NS, Wong BCK, Chan JMC, Wong KH, et al
   Humoral responses to coronavirus disease 2019 vaccines in people with HIV: authors' reply.
   AIDS. 2022;36:1747-1748.
   

   >> Share

   
   
2. MUNGMUNPUNTIPANTIP R, Wiwanitkit V
   Surrogate neutralization responses following SARS-CoV-2 vaccination in people with HIV.
   AIDS. 2022;36:1746-1747.
   

   >> Share

   
   
3. JONAS KJ, Parczewski M, van de Vijver D
   The war refugees from Ukraine: an HIV epidemic is fleeing as well.
   AIDS. 2022;36:1745-1746.
   

   >> Share

   
   
4. LANGLIE J, Mittal R, Bencie NB, Sharma U, et al
   Unraveling the mechanisms of HIV-induced hearing loss.
   AIDS. 2022;36:1737-1740.
   

   >> Share

   
   
5. MARTINEZ E
   The right balance between weight gain and insulin sensitivity with integrase inhibitors.
   AIDS. 2022;36:1735-1736.
   

   >> Share

   
   
6. MILIC J, Guaraldi G
   Hormone therapy in postmenopausal women living with HIV: a view towards prevention of multiple metabolic conditions and improvement of quality of life.
   AIDS. 2022;36:1731-1733.
   

   >> Share

   
   
7. LUBEGA J, Grimes A, Airewele G, Bulsara S, et al
   Risk factors and prognostic significance of anemia in children with hiv infection on anti-retroviral therap.
   AIDS. 2022 Sep 1. pii: 00002030-990000000-00106.
   

   >> Share

   
   

   
   Antivir Ther

8. EUROPEAN PREGNANCY AND PAEDIAT, Lyons A, Thompson L, Chappell E, et al
   Outcomes of etravirine-based antiretroviral treatment in treatment-experienced children and adolescents living with HIV in Europe and Thailand.
   Antivir Ther. 2022;27:13596535221092182.
   

   >> Share

   
   

   
   Clin Infect Dis

9. FISHER BT, Boge CLK, Xiao R, Shuster S, et al
   Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and Adolescents.
   Clin Infect Dis. 2022;75:248-259.
   

   >> Share

   
   
10. SKEGGS J, MacPhail A, Korman T, Woolley I, et al
    Reductions in Antibiotic Prescribing in Australia During the SARS-CoV-2 Pandemic: National Prescribing Data.
    Clin Infect Dis. 2022 Apr 11. pii: 6566296. doi: 10.1093.
    

    >> Share

    
    
11. FERNANDEZ OE, Gudipati S, Ko D, Boucher A, et al
    Papillomatous Anogenital Lesions in a Patient With Human Immunodeficiency Virus.
    Clin Infect Dis. 2022;75:172-175.
    

    >> Share

    
    
12. NELSON BS, Tierney C, Persaud D, Jao J, et al
    Infants Receiving Very Early ART Have High CD4 Counts in the First Year of Life.
    Clin Infect Dis. 2022 Aug 29. pii: 6678126. doi: 10.1093.
    

    >> Share

    
    
13. BURRY J, Casas CP, Ford N
    Access to medicines for treating people with cryptococcal meningitis.
    Clin Infect Dis. 2022 Aug 29. pii: 6678599. doi: 10.1093.
    

    >> Share

    
    
14. SIBIUDE J, Le Chenadec J, Mandelbrot L, Hoctin A, et al
    Update of Perinatal HIV-1 Transmission in France: zero transmission for 5482 mothers on continuous ART from conception and with undetectable viral load at delivery.
    Clin Infect Dis. 2022 Aug 29. pii: 6678600. doi: 10.1093.
    

    >> Share

    
    
15. PETTIT AC, Phillips PP, Kurbatova E, Vernon A, et al
    Rifapentine with and without moxifloxacin for pulmonary tuberculosis in people with HIV (S31/A5349).
    Clin Infect Dis. 2022 Aug 30. pii: 6679254. doi: 10.1093.
    

    >> Share

    
    
16. ROCCO JM, Laidlaw E, Galindo F, Anderson M, et al
    Severe mycobacterial IRIS in advanced HIV has features of hemophagocytic lymphohistiocytosis and requires prolonged immune suppression.
    Clin Infect Dis. 2022 Sep 1. pii: 6681110. doi: 10.1093.
    

    >> Share

    
    
17. CHEW KW, Wu K, Tassiopoulos K, Palella FJ, et al
    Liver inflammation is common and linked to metabolic derangements in persons with treated HIV.
    Clin Infect Dis. 2022 Sep 1. pii: 6682837. doi: 10.1093.
    

    >> Share

    
    
18. GEDELA K, Da Silva Fontoura D, Salam A, Gorman G, et al
    Infectious proctitis due to human monkeypox.
    Clin Infect Dis. 2022 Sep 2. pii: 6683843. doi: 10.1093.
    

    >> Share

    
    

    
    HIV Med

19. KABLAWI D, Alhinai A, Wong P, Deschenes M, et al
    Splenomegaly is a marker of advanced chronic liver disease and portal hypertension in HIV infection.
    HIV Med. 2022 Aug 30. doi: 10.1111/hiv.13390.
    

    >> Share

    
    
20. BALUKU JB, Nabwana M, Mwanahamisi SB, Kansiime G, et al
    Early culture conversion is a poor marker of treatment outcome among people with HIV and drug-resistant TB.
    HIV Med. 2022 Aug 22. doi: 10.1111/hiv.13392.
    

    >> Share

    
    
21. AKSAK-WAS BJ, Kowalska JD, Zabek P, Serwin K, et al
    Immune restoration affects 10-year survival in people living with HIV/AIDS.
    HIV Med. 2022 Aug 25. doi: 10.1111/hiv.13391.
    

    >> Share

    
    

    
    Int J Cancer

22. RASHIDIAN H, Hadji M, Gholipour M, Naghibzadeh-Tahami A, et al
    Opium use and risk of lung cancer: A multicenter case-control study in Iran.
    Int J Cancer. 2022 Aug 13. doi: 10.1002/ijc.34244.
    

    >> Share

    
    
23. DESHMUKH AA, Damgacioglu H, Georges D, Sonawane K, et al
    Global burden of HPV-attributable squamous cell carcinoma of the anus in 2020, according to sex and HIV status: a worldwide analysis.
    Int J Cancer. 2022 Aug 28. doi: 10.1002/ijc.34269.
    

    >> Share

    
    
24. SENGAYI-MUCHENGETI M, Singh E, Chen WC, Bradshaw D, et al
    Thirteen cancers associated with HIV infection in a Black South African cancer patient population (1995-2016).
    Int J Cancer. 2022 Aug 4. doi: 10.1002/ijc.34236.
    

    >> Share

    
    

    
    J Acquir Immune Defic Syndr

25. COBURN SB, Lang R, Zhang J, Palella FJ, et al
    Statins utilization in adults with HIV: The treatment gap and predictors of statin initiation.
    J Acquir Immune Defic Syndr. 2022 Aug 31. pii: 00126334-990000000-00102.
    

    >> Share

    
    
26. COUTINHO CM, Warshaw MG, Duarte G, Stek A, et al
    Effects of initiating raltegravir-based versus efavirenz-based antiretroviral regimens during pregnancy on weight changes and perinatal outcomes: NICHD P1081.
    J Acquir Immune Defic Syndr. 2022 Sep 1. pii: 00126334-990000000-00100.
    

    >> Share

    
    
27. MUYINDIKE WR, Fatch R, Cheng DM, Emenyonu NI, et al
    Unhealthy Alcohol Use is Associated with sub-Optimal Adherence to Isoniazid Preventive Therapy in Persons with HIV in southwestern Uganda.
    J Acquir Immune Defic Syndr. 2022 Aug 30. pii: 00126334-990000000-00101.
    

    >> Share

    
    

    
    J Infect Dis

28. GAYEDYU-DENNIS D, Fallah MP, Drew C, Badio M, et al
    Identifying pauci-/asymptomatic and unrecognized Ebola virus disease among close contacts based on exposure risk assessments and screening algorithms.
    J Infect Dis. 2022 Sep 1. pii: 6679723. doi: 10.1093.
    

    >> Share

    
    

    
    J Med Virol

29. GENG Y, Wang Y
    Stability and transmissibility of SARS-CoV-2 in the environment.
    J Med Virol. 2022 Aug 30. doi: 10.1002/jmv.28103.
    

    >> Share

    
    

    
    Lancet Infect Dis

30. MARX FM, Hesseling AC, Martinson N, Theron G, et al
    National survey in South Africa reveals high tuberculosis prevalence among previously treated people.
    Lancet Infect Dis. 2022;22:1273.
    

    >> Share

    
    
31. BURKI T
    Involuntary sterilisation and HIV.
    Lancet Infect Dis. 2022;22:1284.
    

    >> Share

    
    
32. ONYEGBU C
    The persistence of HIV stigma in Kenya.
    Lancet Infect Dis. 2022;22:1292.
    

    >> Share

    
    
33. ZHAO FH, Wu T, Hu YM, Wei LH, et al
    Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial.
    Lancet Infect Dis. 2022 Aug 26. pii: S1473-3099(22)00435.
    

    >> Share

    
    
34. RAJASINGHAM R, Govender NP, Jordan A, Loyse A, et al
    The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis.
    Lancet Infect Dis. 2022 Aug 29. pii: S1473-3099(22)00499.
    

    >> Share

    
    
35. LAPA D, Carletti F, Mazzotta V, Matusali G, et al
    Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding.
    Lancet Infect Dis. 2022;22:1267-1269.
    

    >> Share

    
    

    
    MMWR Morb Mortal Wkly Rep

36. DELANEY KP, Sanchez T, Hannah M, Edwards OW, et al
    Strategies Adopted by Gay, Bisexual, and Other Men Who Have Sex with Men to Prevent Monkeypox virus Transmission - United States, August 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71.
    

    >> Share

    
    

    
    N Engl J Med

37. CONRADIE F, Bagdasaryan TR, Borisov S, Howell P, et al
    Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.
    N Engl J Med. 2022;387:810-823.
    

    >> Share

    
    
38. PATEL K, Huo Y, Jao J, Powis KM, et al
    Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States.
    N Engl J Med. 2022;387:799-809.
    

    >> Share

    
    

    
    Neurology

39. ZIMBA S, Benjamin L
    A Notable Prevalence of HIV-Associated Stroke in an Endemic Region.
    Neurology. 2022;99:366-367.
    

    >> Share

    
    
40. CORBETT C, Brey N, Pitcher RD, O'Hagan S, et al
    Prevalence and Characteristics of HIV-Associated Stroke in a Tertiary Hospital Setting in South Africa.
    Neurology. 2022;99:e904-e915.
    

    >> Share

    
    

    
    Pediatrics

41. NASH SH, Rutledge M, Frenkel LM, Melvin AJ, et al
    HIV Transmission Through Premastication.
    Pediatrics. 2022 Sep 2. pii: 189361. doi: 10.1542/peds.2021-055422.
    

    >> Share

    
    

    
    PLoS Med

42. PONS-DURAN C, Mombo-Ngoma G, Macete E, Desai M, et al
    Burden of malaria in pregnancy among adolescent girls compared to adult women in 5 sub-Saharan African countries: A secondary individual participant data meta-analysis of 2 clinical trials.
    PLoS Med. 2022;19:e1004084.
    

    >> Share

    
    

    
    PLoS One

43. BUSKIN SE, Lechtenberg RJ, Slaughter FA, Herbeck JT, et al
    A public health approach to monitoring HIV with resistance to HIV pre-exposure prophylaxis.
    PLoS One. 2022;17:e0272958.
    

    >> Share

    
    
44. MORADI G, Gouya MM, Ezzati Amini E, Ghorbani SS, et al
    Intentional abortion and its associated factors among female sex workers in Iran: Results from national bio-behavioral surveillance-2020.
    PLoS One. 2022;17:e0273732.
    

    >> Share

    
    
45. JAHUN I, Ehoche A, Bamidele M, Yakubu A, et al
    Evaluation of accuracy and performance of self-reported HIV and antiretroviral therapy status in the Nigeria AIDS Indicator and Impact Survey (2018).
    PLoS One. 2022;17:e0273748.
    

    >> Share

    
    
46. BARAL S, Rao A, Rwema JOT, Lyons C, et al
    Competing health risks associated with the COVID-19 pandemic and early response: A scoping review.
    PLoS One. 2022;17:e0273389.
    

    >> Share

    
    
47. NSIBANDE DF, Woldesenbet SA, Puren A, Barron P, et al
    Investigating the quality of HIV rapid testing practices in public antenatal health care facilities, South Africa.
    PLoS One. 2022;17:e0268687.
    

    >> Share

    
    
48. COSTA-CORDELLA S, Grasso-Cladera A, Rossi A, Duarte J, et al
    Internet-based peer support interventions for people living with HIV: A scoping review.
    PLoS One. 2022;17:e0269332.
    

    >> Share

    
    
49. MCANDREW BM, Gil N, Lee DP, Teklehaimanot S, et al
    An exploratory study to characterize the HIV testing-to-care continuum to improve outcomes for Black and Latinx residents of South Los Angeles.
    PLoS One. 2022;17:e0268374.
    

    >> Share

    
    
50. IYER A, Shah J, Shah R
    The burden and characteristics of HIV-infected COVID-19 patients at a tertiary care hospital in sub-Saharan Africa-A retrospective cohort study.
    PLoS One. 2022;17:e0273859.
    

    >> Share

    
    
51. KARUGABA G, Simpson J, Mathuba B, Phoi O, et al
    The barriers and facilitators of HIV-exposed infant testing as perceived by HIV-positive mothers in Botswana: A qualitative study.
    PLoS One. 2022;17:e0273777.
    

    >> Share

    
    
52. REDDY K, Kemigisha D, Chitukuta M, Dadabhai S, et al
    ''Ask the way from those who have walked it before"-Grandmothers' roles in health-related decision making and HIV pre-exposure prophylaxis use among pregnant and breastfeeding women in sub-Saharan Africa.
    PLoS One. 2022;17:e0271684.
    

    >> Share

    
    
53. KIM E, Jonnalagadda S, Cuervo-Rojas J, Jahn A, et al
    Toward elimination of mother-to-child transmission of HIV in Malawi: Findings from the Malawi Population-based HIV Impact Assessment (2015-2016).
    PLoS One. 2022;17:e0273639.
    

    >> Share

    
    
54. ALMEIDA MM, Silva LAVD, Bastos FI, Guimaraes MDC, et al
    Factors associated with symptoms of major depression disorder among transgender women in Northeast Brazil.
    PLoS One. 2022;17:e0267795.
    

    >> Share

    
    
55. RAPITI N, Abdelatif N, Moosa MS
    Prognostic variables and 4-year survival outcomes in CD20 Positive AIDS-Related Lymphoma in the Anti-retroviral treatment era: A Retrospective Review from a Single Centre in KwaZulu-Natal, South Africa.
    PLoS One. 2022;17:e0272282.
    

    >> Share

    
    
56. GONDWE Y, Kudowa E, Tomoka T, Kasonkanji ED, et al
    Comparison of baseline lymphoma and HIV characteristics in Malawi before and after implementation of universal antiretroviral therapy.
    PLoS One. 2022;17:e0273408.
    

    >> Share

    
    

    
    PLoS Pathog

57. SCHEEPERS C, Kgagudi P, Mzindle N, Gray ES, et al
    Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies.
    PLoS Pathog. 2022;18:e1010450.
    

    >> Share

    
    
58. GUO S, Luke BT, Henry AR, Darko S, et al
    HIV infected CD4+ T cell clones are more stable than uninfected clones during long-term antiretroviral therapy.
    PLoS Pathog. 2022;18:e1010726.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

59. LUTZ EA, Agarwal Y, Momin N, Cowles SC, et al
    Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies.
    Proc Natl Acad Sci U S A. 2022;119:e2205983119.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share